RxDoctor Payments Data

Edwin Palmer, MD

Nuclear Radiology · Boston, MANPI 1962492231

Payments from drug & device makers

$126,750in general payments, 2019–2025

Across 50 payments — averaging $2535.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hoffmann-la Roche Limited$87K
  • Astellas Pharma Global Development$18K
  • Pfizer$11K
  • GSK$10K

What the payments were for

  • Consulting fees$11,100100%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Hoffmann-la Roche Limited9$87,250
Astellas Pharma Global Development4$18,410
Pfizer24$11,100
GSK13$9,990

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few nuclear radiology providers in Massachusettsto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$35,571
Medicare patients
343
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear radiology in Boston

Where these figures come from

Is this you, or does something look wrong? →